JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
NCT:NCT05064540 · RECRUITING
广告
NCT编号NCT05064540
状态RECRUITING
开始日期2021-09-20
SponsorEndologix (INDUSTRY)
First posted
Last updated
简要摘要
Prospective, randomized, multi-center study designed to evaluate the outcomes of commercially available contemporary EVAR in a real-world population. Patients will be randomized into two device cohorts and compared across the primary endpoints. Patients will be followed procedurally to discharge, at 1, 6, 12 months and annually through to 5 years (total follow-up commitment).
官方来源
在 ClinicalTrials.gov 上查看 →数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。